Related Experiment Video
Updated: Nov 1, 2025

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Dual Function Antimicrobial Loaded Lectin Carrier: A Strategy to Overcome Biomolecular Interference without
Siva Bala Subramaniyan1, Subburethinam Ramesh1, Senthilnathan Rajendran1
1Department of Chemistry, School of Chemical & Biotechnology, Shanmugha Arts, Science, Technology & Research Academy (SASTRA) Deemed University, Thanjavur-613401, Tamil Nadu, India.
Researchers developed novel lectin conjugates (BcNAE) that overcome serum protein interference, enhancing antimicrobial activity against uropathogenic Escherichia coli. These conjugates show low toxicity and prevent resistance development, offering a promising therapeutic strategy.
Area of Science:
- Biochemistry and Molecular Biology
- Antimicrobial Drug Development
- Nanotechnology in Medicine
Background:
- Drug disposition is affected by biological fluids, with protein binding impacting activity.
- Cationic N-acylethanolamine (cNAE) antimicrobial activity is hindered by serum protein interference.
- Butea monosperma seed lectin (BMSL) can be formulated to mitigate such interferences.
Purpose of the Study:
- To develop a noncovalent formulation of BMSL and cNAE (BcNAE) to overcome serum protein interference.
- To evaluate the antimicrobial efficacy and resistance potential of BcNAE against uropathogenic Escherichia coli (UPEC).
- To assess the biosafety and therapeutic potential of BcNAE in preclinical models.
Main Methods:
- Noncovalent formulation of BMSL and cNAE.
- Fluorescence spectroscopy and molecular docking to study complex formation.
- Minimum inhibitory concentration (MIC) assays, membrane depolarization studies, resistance development assays.
- Hemocompatibility tests, zebrafish infection model for efficacy and biosafety assessment.
Main Results:
- BcNAE conjugates effectively mitigated serum protein interference, showing a 4-fold lower MIC (7.81 μM) than pure cNAE against UPEC.
- BcNAE demonstrated potent antimicrobial activity by depolarizing bacterial membranes and preventing resistance development even after 25 passages.
- Zebrafish studies confirmed BcNAE's efficacy, safety, and rapid clearance of UPEC infection with restored tissue pathology and increased survival.
Conclusions:
- Lectin-lipid conjugates (BcNAE) offer a novel strategy to enhance antimicrobial efficacy by overcoming biological fluid interference.
- BcNAE exhibits potent, membrane-targeting antimicrobial activity with a low propensity for resistance development and good biosafety.
- BcNAE represents a promising candidate for developing new therapeutics against challenging bacterial infections.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Bioavailability Enhancement: Drug Permeability Enhancement

